Editor's Note Social risk factors were inconsistently associated with surgical site infection (SSI) rates after colectomy or abdominal hysterectomy in this study. In this analysis of 149,741 patients, Medicaid status (a marker for poverty) and living in a low-income zip code were linked to higher SSI rates after colectomy. For…

Read More

Enhanced Recovery After Surgery (ERAS®) is a comprehensive, multifaceted, and multidisciplinary approach to the care of the surgical patient. ERAS bundles evidence-based elements to facilitate a faster recovery with fewer complications.1 Spanning the continuum of perioperative care, ERAS elements include: • patient engagement and education • preoperative optimization of nutrition…

Read More

Editor's Note Because of the potential risk of selecting mutants carrying genes for cross-resistance to chlorhexidine gluconate (CHG) and antibiotics, it is advisable to reserve the use of CHG for purposes other than hand hygiene, this study finds. A review of studies showed no significant difference in healthcare-associated infection rates…

Read More

Editor's Note Hospitals that perform better on measures to prevent postoperative complications also have better performance on measures of profitability, this study finds. Improved patient safety performance was associated with higher net patient revenue for five of seven Surgical Care Improvement Project (SCIP) measures, including starting and stopping preventive antibiotics…

Read More

Editor's Note In this multi-center study, longer durations of surgical prophylaxis did not result in further reductions in surgical site infections (SSIs) but were associated with increasing adverse events. Of 79,058 surgical patients in the VA healthcare system, SSI was not associated with duration of prophylaxis, but odds of acute…

Read More

Editor's Note The Joint Commission on January 9 announced that it is seeking feedback on its newly proposed requirements for antimicrobial stewardship at Medication Management (MM) standard MM.09.01.03. The requirements apply to ambulatory healthcare organizations and office-based surgery practices. The proposed requirements align with current recommendations from scientific and professional…

Read More

Editor's Note Antimicrobial treatment of asymptomatic organisms identified in preoperative urine cultures was not associated with reductions in the risk for postoperative infections, including urinary tract infections (UTIs) and surgical site infections (SSIs), this study finds. In this analysis of 68,265 patients in 109 Veterans Affairs hospitals who had cardiac,…

Read More

Editor's Note The Food and Drug Administration (FDA) on December 20 announced that fluoroquinolone antibiotics can increase the occurrence of ruptures or tears in the aorta. The FDA recommends that healthcare professionals: Avoid prescribing fluoroquinolone antibiotics to patients who have or are at risk for having an aortic aneurysm, and…

Read More

Editor's Note The Food and Drug Administration (FDA) on August 3 issued a warning for azithromycin, saying the antibiotic should not be given long-term to prevent an inflammatory lung condition in patients with cancers of the blood or lymph nodes who undergo a donor stem cell transplant. A clinical trial…

Read More

Editor's Note The Food & Drug Administration announced on July 10 that it was requiring labeling changes for fluoroquinolone antibiotics because they may cause significant decreases in blood sugar and mental health side effects. The labels will add that low blood sugar levels can lead to coma and make the…

Read More